measl
mv
extrem
contagi
human
diseas
character
fever
exanthema
infl
ammat
eye
respiratori
tract
neihart
liu
measl
typic
diseas
children
caus
sever
pneumonia
diarrhea
enceph
death
yanagi
et
al
despit
avail
effect
live
vaccin
measl
still
respons
death
children
younger
year
age
worldwid
synonym
rubeola
classifi
cation
famili
paramyxovirida
genu
morbilliviru
epidemiolog
mv
outbreak
usual
occur
late
winterearli
spring
transmiss
via
aerosol
droplet
hayward
rall
mv
one
highli
contagi
infecti
agent
outbreak
occur
popul
less
individu
suscept
introduct
measl
vaccin
person
would
becom
immun
age
result
natur
acquir
infect
studi
hedrich
baltimor
show
measl
epidem
relat
small
fl
uctuat
suscept
popul
age
year
age
epidem
occur
suscept
popul
reach
ceas
level
reduc
level
herd
immun
protect
popul
epidem
reach
children
age
guarante
reservoir
suscept
individu
endem
measl
schaffner
et
al
estim
nonimmun
peopl
expos
infect
individu
becom
infect
moreov
infect
individu
contagi
day
appear
characterist
rash
increas
risk
transmiss
contagi
mv
best
express
basic
reproduct
number
ro
mean
number
secondari
case
would
aris
infecti
agent
introduc
complet
suscept
popul
estim
ro
mv
gener
assum
measl
mv
extrem
contagi
human
diseas
character
fever
exanthema
infl
ammat
eye
respiratori
tract
neihart
liu
measl
typic
diseas
children
caus
sever
pneumonia
diarrhea
enceph
death
yanagi
et
al
despit
avail
effect
live
vaccin
measl
still
respons
death
children
younger
year
age
worldwid
synonym
rubeola
famili
paramyxovirida
genu
morbilliviru
mv
outbreak
usual
occur
late
winterearli
spring
transmiss
via
aerosol
droplet
hayward
rall
mv
one
highli
contagi
infecti
agent
outbreak
occur
popul
less
individu
suscept
introduct
measl
vaccin
person
would
becom
immun
age
result
natur
acquir
infect
studi
hedrich
baltimor
show
measl
epidem
relat
small
fl
uctuat
suscept
popul
age
year
age
epidem
occur
suscept
popul
reach
ceas
level
reduc
level
herd
immun
protect
popul
epidem
reach
children
age
guarante
reservoir
suscept
individu
endem
measl
schaffner
et
al
estim
nonimmun
peopl
expos
infect
individu
becom
infect
moreov
infect
individu
contagi
day
appear
characterist
rash
increas
risk
transmiss
contagi
mv
best
express
basic
reproduct
number
ro
mean
number
secondari
case
would
aris
infecti
agent
introduc
complet
suscept
popul
estim
ro
mv
gener
assum
contrast
smallpox
viru
sar
coronaviru
rima
duprex
monto
moss
griffi
n
high
infect
mv
impli
high
level
popul
immun
approxim
requir
interrupt
mv
transmiss
monto
viru
remain
transmiss
air
infect
surfac
h
obviat
need
direct
persontoperson
contact
monto
measl
viru
close
resembl
rinderpest
viru
recent
erad
pathogen
cattl
probabl
evolv
ancestr
viru
zoonot
infect
commun
cattl
human
live
close
proxim
moss
griffi
n
measl
viru
spheric
envelop
nonseg
negativestrand
rna
genom
moss
griffi
n
fig
genom
contain
six
gene
encod
eight
protein
divid
two
main
type
envelopeassoci
ribonucleoprotein
rnp
associ
protein
major
compon
nucleoprotein
core
ribonucleoprotein
two
part
larg
protein
phosphoprotein
larg
protein
compos
enzym
rna
polymeras
catalyz
transcript
replic
nucleocapsid
templat
yanagi
et
al
envelop
made
matrix
protein
hemagglutinin
protein
fusion
protein
attach
virion
host
cell
mediat
hemagglutinin
protein
follow
process
fusion
hemagglutinin
protein
mediat
entri
host
cell
known
measl
viru
receptor
human
cell
signal
lymphocyt
activ
molecul
slam
membran
cofactor
protein
regul
complement
activ
play
import
part
protect
host
cell
spontan
complement
attack
yanagi
et
al
measl
viru
one
serotyp
therefor
prevent
singl
monoval
vaccin
infect
person
transmit
mv
via
respiratori
droplet
deliv
infecti
viru
epitheli
cell
respiratori
tract
suscept
host
incub
period
mv
replic
spread
infect
host
type
pneumocyt
alveolar
macrophag
respiratori
epitheli
cell
becom
infect
yet
unknown
initi
site
viral
replic
viru
spread
local
lymphat
tissu
replic
follow
viremia
dissemin
mani
organ
includ
lymph
node
skin
kidney
gastrointestin
tract
liver
viru
replic
epitheli
endotheli
cell
lymphocyt
monocyt
macrophag
griffi
n
measl
immun
involv
humor
cellular
mucos
respons
cellmedi
immun
requir
recoveri
measl
humor
immun
associ
protect
infect
reinfect
moss
griffi
n
mv
infect
result
immunosuppress
depress
respons
nonmv
antigen
effect
last
sever
week
month
resolut
acut
ill
patient
measl
show
suppress
delayedtyp
hypersensit
dth
respons
recal
antigen
tuberculin
impair
cellular
humor
respons
new
antigen
mvinduc
immun
suppress
render
individu
suscept
secondari
bacteri
viral
infect
caus
pneumonia
diarrhea
respons
much
measlesrel
morbid
mortal
moss
griffi
n
pneumonia
common
fatal
complic
measl
occur
measlesrel
death
duke
mgone
product
reduc
product
inhibit
dth
respons
downregul
synthesi
cytokin
suppress
macrophag
activ
tcell
prolifer
elev
sever
week
plasma
children
measl
yanagi
et
al
measl
skin
rash
thought
caus
tcell
respons
mvinfect
cell
capillari
vessel
appear
children
tcell
immunodefi
cienci
yanagi
et
al
incub
period
day
prodrom
measl
begin
fever
c
cough
coryza
conjunct
fig
initi
present
resembl
cold
except
fever
earli
sign
symptom
worsen
period
sneez
rhiniti
congest
common
cough
frequent
troublesom
often
brassi
qualiti
suggest
laryng
tracheal
involv
mucou
membran
line
cheek
opposit
molar
teeth
examin
found
major
patient
white
bluishgray
spot
size
pinhead
red
margin
known
koplik
spot
pathognomon
exanthem
measl
rash
start
behind
ear
spread
face
trunk
within
h
rash
deep
pink
red
color
appear
blotch
scatter
littl
island
unaffect
skin
prurit
rash
spread
cover
entir
bodi
day
kilbourn
unusu
rash
persist
day
fade
skin
appear
dri
superfi
cial
layer
scale
fever
usual
last
day
within
day
appear
rash
children
towsley
complic
measl
larg
attribut
pathogen
effect
viru
respiratori
tract
immun
system
axton
acut
otiti
media
common
complic
pneumonia
common
caus
death
measl
croup
tracheiti
bronchiol
common
complic
infant
toddler
measl
moss
griffi
n
duke
mgone
perri
halsey
pneumonia
sever
complic
measl
note
account
measlesassoci
death
studi
unselect
hospit
children
measl
radiograph
chang
bronchopneumonia
consolid
infi
ltrate
children
sever
diseas
children
mild
diseas
radiograph
chang
recent
year
pneumonia
present
children
year
old
measl
unit
state
case
outbreak
adult
pneumonia
may
caus
measl
viru
alon
secondari
viral
infect
adenoviru
hsv
secondari
bacteri
infect
measl
one
caus
hecht
giant
cell
pneumonia
usual
occur
immunocompromis
person
occur
otherwis
normal
adult
children
studi
includ
cultur
blood
lung
punctur
tracheal
aspir
reveal
bacteria
caus
measlesassoci
pneumonia
pneumonia
aureu
h
infl
uenza
commonli
isol
organ
bacteria
eg
pseudomona
speci
klebsiella
pneumonia
e
coli
less
common
caus
sever
pneumonia
associ
measl
studi
young
adult
militari
recruit
pneumonia
associ
measl
neisseria
meningitidi
probabl
caus
case
perri
halsey
ender
et
al
mitu
et
al
ellison
diarrhea
vomit
common
symptom
associ
acut
measl
append
may
occur
obstruct
appendic
lumen
lymphoid
hyperplasia
febril
seizur
occur
children
measl
moss
griffi
n
duke
mgone
measl
infect
known
suppress
skin
test
respons
purifi
ed
tuberculin
antigen
may
higher
rate
activ
pulmonari
tuberculosi
popul
individu
infect
mycobacterium
tuberculosi
expos
measl
griffi
n
three
seriou
complic
measl
occur
cn
acut
demyelin
encephalomyel
adem
measl
inclus
bodi
enceph
mibe
subacut
scleros
panenceph
sspe
last
two
invari
fatal
adem
develop
week
appear
rash
seen
infect
children
approxim
patient
adem
die
suffer
longterm
sequela
includ
mental
retard
motor
disabl
deaf
mibe
seen
immunocompromis
patient
month
acut
infect
vaccin
sspe
caus
persist
measl
viru
infect
develop
year
initi
infect
rima
duprex
perri
halsey
find
cerebrospin
fl
uid
csf
includ
lymphocyt
pleocytosi
case
elev
protein
concentr
sever
form
measl
rare
seen
hemorrhag
measl
black
measl
manifest
hemorrhag
skin
erupt
often
fatal
kerat
appear
multipl
punctat
epitheli
foci
resolv
recoveri
infect
thrombocytopenia
sometim
occur
follow
measl
kilbourn
myocard
rare
complic
measl
miscellan
bacteri
infect
report
includ
bacteremia
cellul
toxic
shock
syndrom
measl
pregnanc
associ
high
matern
morbid
fetal
wastag
stillbirth
congenit
malform
live
born
infant
moss
griffi
n
extrapulmonari
patholog
manifest
measl
particularli
skin
lymph
node
well
known
turn
attent
pneumon
caus
measl
viru
chang
lung
includ
peribronchi
interstiti
mononuclear
cell
infi
ltrate
squamou
metaplasia
bronchial
epithelium
prolifer
type
ii
pneumocyt
format
hyalin
membran
latter
chang
indic
diffus
alveolar
damag
complic
case
may
evolv
abscess
format
empyema
prototyp
pulmonari
chang
howev
develop
multinucl
giant
cell
characterist
nuclear
cytoplasm
inclus
fig
cell
also
report
variou
lymphoreticular
tissu
throughout
bodi
typic
larg
contain
nuclei
numer
count
absenc
multinucl
giant
cell
lung
may
occur
regard
exclusionari
evid
measl
pneumonia
convers
presenc
multinucl
giant
cell
diagnost
measl
pneumonia
giant
cell
pneumonialik
pictur
may
seen
varieti
granulomat
disord
importantli
giant
cell
pneumonia
manifest
viral
pneumonia
includ
case
giant
cell
pneumonia
secondari
respiratori
syncyti
viru
parainfl
uenza
nipah
virus
latter
less
like
sinc
known
occur
europ
unit
state
viral
inclus
also
found
pneumonia
due
herp
simplex
herp
zoster
adenoviru
viral
infect
morpholog
differ
gener
repres
diagnost
problem
zaki
paddock
radoycich
et
al
detect
measlesspecifi
c
immunoglobulin
igm
serum
standard
test
rapid
laboratori
diagnosi
measl
igm
test
commonli
perform
use
commerci
enzym
immunoassay
eia
kit
number
commerci
avail
igm
assay
measl
use
indirect
format
format
requir
blockag
igg
antibodi
rheumatoid
factor
pretreat
step
ensur
optim
perform
igm
assay
base
captur
format
develop
measl
moss
griffi
n
assay
requir
remov
igg
antibodi
consid
slightli
specifi
c
technic
easier
perform
indirect
eia
detect
igm
antibodi
although
longer
routin
use
diagnosi
acut
measl
infect
detect
rise
specifi
c
igg
serum
sampl
collect
acut
convalesc
phase
use
confi
rm
infect
igg
assay
reli
collect
two
sampl
day
apart
also
use
confi
rmation
sporad
case
igm
result
equivoc
system
direct
detect
measl
rubella
rtpcr
becom
common
although
standard
method
becom
establish
singl
standard
method
yet
develop
wellestablish
wide
use
method
rtpcr
detect
measl
develop
center
diseas
control
prevent
atlanta
usa
cdc
health
protect
agenc
london
uk
hpa
avail
relev
laboratori
upon
request
although
recommend
routin
laboratori
diagnosi
cultur
measl
rubella
viru
clinic
specimen
import
compon
measl
control
strategi
often
diagnosi
measl
made
without
diffi
culti
clinic
ground
viral
infect
condit
caus
cutan
rash
rubella
dengu
fever
drug
reaction
consid
case
atyp
symptomatolog
histolog
giant
cell
c
fig
continu
multinucl
set
interstiti
pneumon
help
indic
viral
pathogen
respiratori
syncyti
viru
human
metapneumoviru
parainfl
uenza
henipah
virus
may
also
associ
multinucl
giant
cell
immunohistochem
studi
case
use
highlight
viral
antigen
point
specifi
c
etiolog
laboratori
test
outlin
see
diagnosi
help
diagnost
tool
specifi
c
antivir
treatment
measl
treatment
vitamin
result
reduct
morbid
mortal
children
measl
recommend
administr
daili
dose
iu
vitamin
consecut
day
children
age
month
older
measl
lower
dose
recommend
younger
children
iu
per
day
children
age
month
iu
per
day
children
younger
month
children
clinic
evid
vitamin
defi
cienci
third
dose
recommend
week
later
moss
griffi
n
griffi
n
duke
mgone
treatment
antibiot
indic
patient
measl
develop
secondari
bacteri
infect
antibiot
indic
individu
measl
clinic
evid
pneumonia
otiti
media
streptococcu
pneumonia
haemophilu
infl
uenza
type
b
common
caus
bacteri
pneumonia
measl
vaccin
pathogen
probabl
lower
incid
secondari
bacteri
infect
measl
moss
griffi
n
measl
like
polio
smallpox
host
except
man
therefor
erad
measl
possibl
suscept
measl
immun
zaki
paddock
measl
viru
fi
rst
isol
tissu
cultur
edmonston
strain
sinc
kill
viru
vaccin
edmonston
live
attenu
vaccin
edmonston
b
introduc
use
global
markowitz
et
al
kill
vaccin
use
incomplet
protect
mmwr
introduct
measl
vaccin
approxim
three
four
million
us
case
annual
estim
popul
diseas
age
measl
vaccin
one
costeffect
health
intervent
ever
develop
perri
halsey
thank
use
measl
vaccin
measl
declar
elimin
unit
state
although
sporad
case
continu
occur
owe
import
current
live
attenu
vaccin
use
unit
state
shown
protect
properli
immun
children
prevent
measl
mump
rubella
varicella
mmrv
advisori
committe
immun
practic
acip
recommend
vaccin
schedul
childhood
fi
rst
dose
administ
age
month
second
dose
age
year
acad
ped
mmrv
vaccin
may
administ
simultan
vaccin
recommend
children
age
month
year
simultan
administr
possibl
mmrv
vaccin
may
administ
time
inactiv
vaccin
least
day
anoth
live
attenu
vaccin
except
varicella
vaccin
minimum
interv
month
recommend
live
attenu
viru
vaccin
contraind
patient
alter
immun
ie
blood
dyscrasia
leukemia
lymphoma
type
malign
neoplasm
affect
bone
marrow
lymphat
system
primari
acquir
immunodefi
cienci
includ
hiv
infectionsaid
cellular
immun
defi
cienci
hypogammaglobulinemia
dysgammaglobulinemia
famili
histori
congenit
hereditari
immunodefi
cienci
unless
immun
compet
potenti
vaccin
recipi
demonstr
system
immunosuppress
therapi
includ
oral
steroid
mgkg
bodi
weight
mgday
prednison
equival
person
weigh
kg
administ
week
pregnanc
mmwr
measl
immun
contraind
children
hiv
infect
sever
immunocompromis
acad
ped
highli
contagi
diseas
measl
typic
diseas
children
despit
avail
effect
live
vaccin
diseas
still
respons
diseas
children
younger
year
age
worldwid
viru
transmit
via
respiratori
droplet
deliv
infecti
particl
epitheli
cell
respiratori
tract
suscept
nest
pneumonia
major
complic
character
part
presenc
multinucl
giant
cell
differenti
diagnosi
includ
giant
cell
pneumonia
due
parainfl
uenza
respiratori
syncyti
viru
among
other
effect
vaccin
avail
help
declar
measl
elimin
unit
state
howev
sporad
case
continu
occur
owe
failur
seek
vaccin
select
popul
group
